| 1. |
Committee’s Official Designation:
Advisory Committee on the Medical Uses of Isotopes
Established Pursuant to Section 9 of Public Law 92-463 as an NRC discretionary
committee. |
| 2. |
Committee’s objectives, scope of activities and duties are as follows:
The Committee provides advice, as requested by the Director, Division of Materials
Safety and State Agreements (MSSA), Office of Federal and State Materials and
Environmental Management Programs (FSME), on policy and technical issues that arise
in regulating the medical use of byproduct material for diagnosis and therapy. The
Committee may provide consulting services as requested by the Director, MSSA. |
| 3. |
Time period (duration of this Committee):
Continuing Committee. |
| 4. |
Official to whom this Committee reports:
Director, Division of Materials Safety and State Agreements
Office of Federal and State Materials and Environmental Management Programs
U.S. Nuclear Regulatory Commission
Washington, DC 20555 |
| 5. |
Agency responsible for providing necessary support to this Committee:
U.S. Nuclear Regulatory Commission. |
| 6. |
The duties of the Committee are set forth in Item 2 above. |
| 7. |
Estimated annual direct cost of this Committee:
Members are appointed by the Director, Office of Federal and State Materials and
Environmental Management Programs as Special Government Employees (SGEs).
Approximately 12 members utilize 1 FTE (includes approximately 0.6 FTE for NRC staff
and 0.4 FTE for ACMUI member compensation and travel). |
| 8. |
Estimated number of meetings per year:
Five meetings per year, three of which are teleconferences. |
| 9. |
The Committee’s termination date.
Continuing Committee subject to Charter renewal on March 17, 2010. |
| 10. |
Filing date:
March 17, 2008 |
| |
Andrew L. Bates
Advisory Committee Management Officer
Office of the Secretary of the Commission |
